Dexamethasone Sodium Phosphate Injection
Somerset Therapeutics, LLC · Available
Open FDA's page for this record- Update type
- Reverified
- Initial posting date
- 02/08/2019
- Package NDC
- 70069-021-25
- Generic name
- Dexamethasone Sodium Phosphate Injection
- Contact info
- 732-554-1019
- Availability
- Available
- Update date
- 09/11/2026
- Dosage form
- Injection
- Presentation
- Dexamethasone Sodium Phosphate Preservative Free, Injection, 10 mg/1 mL (NDC 70069-021-25)
- Company name
- Somerset Therapeutics, LLC
- Status
- Current
- Therapeutic category
- Dermatology, Endocrinology/Metabolism, Gastroenterology, Hematology, Neurology, Oncology, Ophthalmology, Other, Pulmonary/Allergy, Rheumatology
- Harmonized identifiers (openFDA)
- Application number
- ANDA207442
- Brand name
- DEXAMETHASONE SODIUM PHOSPHATE
- Generic name
- DEXAMETHASONE SODIUM PHOSPHATE
- Manufacturer name
- Somerset Therapeutics, LLC
- Product NDC
- 70069-021
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- INTRAMUSCULAR, INTRAVENOUS
- Substance name
- DEXAMETHASONE SODIUM PHOSPHATE
- RxCUI
- 1812079
- SPL ID
- 73618326-ff56-4a30-9d6d-6b019b61c2cd
- SPL set ID
- 799028e2-c0e4-494f-89ff-1b786babc34a
- Package NDC
- 70069-021-01, 70069-021-25
- UNII
- AI9376Y64P